8/13/2025Merck Halts NSCLC Development of MK-1308 Amid Partnership with China's...

8/13/2025NHSA Publishes Preliminary Review Results for 2025 NRDL Adjustments wi...

8/12/2025Akeso Doses First Patient in Phase III Trial of Ivonescimab

8/11/2025Novo Nordisk Reports Solid Growth in China Amid Global Expansion in H1...

8/8/2025Minghui's MHB042C Earns Green Light for Clinical Trials in Advanced So...

8/8/2025AstraZeneca Expands Use of Fasenra in China

8/8/2025Minghui Raises $131M to Accelerate Clinical and Commercial Expansion

8/8/2025Shanghai Unveils 18 New Measures to Boost Commercial Health Insurance ...

8/8/2025Triple Squeeze Threatens China's Global Drug Push

8/8/2025Hengrui Launches Phase 3 Trial of Trastuzumab Rezetecan Combo for AGC

8/8/2025Wuxi Apptec Strengthens European Foothold with Luxembourg Expansion Am...

8/8/2025Recent Executive Moves

8/8/2025Pharma MNCs in China H1/2025 – Mature Products Exit, Top Performers R...

8/8/2025China Biopharma Tracker – July 2025: Funding Surges and Major Deals (...

8/7/2025Innovation through Talent: How Leadership Is Evolving in China's Life ...

8/6/2025Big Pharma Provides Lifeline to Chinese Companies Struggling To Surviv...

8/6/2025Fosun's Exit from Gland Pharma Stalls as Share Price Surge Complicates...

8/6/2025MediLink and Akeso Launch First ADC–Ivonescimab Combo Trial

8/6/2025China Launches 11th National VBP Round with New Flexibility for Hospit...

8/6/2025Global Pharma Bets on China's AI Biotech for Next-Gen Drug Discovery

8/6/2025China Urges Price Discipline as Drugmakers Flood Latest VBP Tender

8/5/2025Sanofi Withdraws Praluent from China Amid Strategic Shift

8/5/2025China Issues 2025 Code of Ethics for Medical Professionals

8/5/2025China Seeks Public Feedback on New Internet Drug and Device Informatio...

8/5/2025Sanofi Attributes Praluent's China Exit to Global Supply Strain and St...

8/5/2025MediLink and Akeso Launch First Clinical Trial Combining Ivonescimab w...

8/5/2025China Approves AstraZeneca's Ultomiris for AQP4+ NMOSD

8/5/2025Metis Raises CNY 400M in Series D to Fuel AI-Driven Drug Development

8/5/2025CSPC's Chemically Synthesized Semaglutide Injection Accepted for Revie...

8/5/2025EMBIOS Secures Pre-A Funding to Advance First-in-Class Autoimmune Ther...

Page:1/364 Total number of articles:10915: [First][<<] [1] [2] [3] [4] [5] [>>] [End]